April 11, 2002
VIA EDGAR
---------
Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C. 20549-1004
Attention: Filing Desk, Stop 1-4
Re: Spectrian Corporation
Current Report on Form 8-K
--------------------------
Ladies and Gentlemen:
On behalf of Spectrian Corporation, a Delaware corporation
(the "Company"), we file herewith via EDGAR one copy of a Current
Report on Form 8-K for the Company reporting the execution of its
Amendment No. 2 of its Purchase and Supply Agreement with UltraRF,
Inc., a wholly owned subsidiary of Cree, Inc., dated April 5,
2002.
Please direct any questions or comments regarding this
filing to Julia Reigel at 650-320-4509 or me at 650-565-3643.
Very truly yours,
WILSON SONSINI GOODRICH & ROSATI
Professional Corporation
/s/ Robert S. Devens, Jr.
ROBERT S. DEVENS, JR.
Enclosures
cc: Michael D. Angel
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report Pursuant
to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) April 5, 2002
-------------------------------
SPECTRIAN CORPORATION
- --------------------------------------------------------------------------------
(Exact Name of the Registrant as Specified in Its Charter)
Delaware
- --------------------------------------------------------------------------------
(State or Other Jurisdiction of Incorporation)
0-24360 77-0023003
------------------------ ------------------------------------
(Commission File Number) (I.R.S. Employer Identification No.)
350 West Java Drive, Sunnyvale, California 94089
- --------------------------------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
(408) 745-5400
- --------------------------------------------------------------------------------
(Registrant's Telephone Number, Including Area Code)
- --------------------------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
Item 5. Other Events.
On April 5, 2002, Spectrian Corporation (the "Company") entered into
Amendment No. 2 to the Purchase and Supply Agreement with UltraRF, Inc., a
wholly owned subsidiary of Cree, Inc. (the "Amendment").
A copy of the Amendment is attached hereto as Exhibit 10.48.2. Exhibit
10.48.2 is incorporated by reference into this Item 5 and the foregoing
description is qualified in its entirety by reference to such Exhibit.
Item 7. Financial Statements and Exhibits.
(c) Exhibits
Exhibit
Number Description
------- -----------
10.48.2 Amendment No. 2 to the Purchase and Supply Agreement,
dated April 5, 2002, between the Company and UltraRF,
Inc. (formerly known as Zoltar Acquisition, Inc.), a
wholly owned subsidiary of Cree, Inc.
- ----------------------
* Confidential treatment has been requested with respect to certain portions
of this exhibit. Omitted portions have been filed separately with the
Securities and Exchange Commission.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Dated: April 11, 2002
SPECTRIAN CORPORATION
By: /s/ Thomas H. Waechter
-------------------------------------------
Thomas H. Waechter
President and Chief Executive Officer
By: /s/ Michael D. Angel
--------------------------------------------
Michael D. Angel
Executive Vice President, Finance and
Administration, Chief Financial Officer and
Secretary
SPECTRIAN CORPORATION
FORM 8-K
INDEX TO EXHIBITS
Exhibit
Number Description
------- -----------
10.48.2 Amendment No. 2 to the Purchase and Supply Agreement, dated
April 5, 2002, between the Company and UltraRF, Inc. (formerly
known as Zoltar Acquisition, Inc.), a wholly owned subsidiary
of Cree, Inc.
- ----------------------
* Confidential treatment has been requested with respect to certain portions
of this exhibit. Omitted portions have been filed separately with the
Securities and Exchange Commission.